Actionable news
All posts from Actionable news
Actionable news in PGNX: Progenics Pharmaceuticals Inc.,

On October

Progenics and its licensee for RELISTOR, Salix Pharmaceuticals, Inc. (a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc.) are assessing the notification and intend to vigorously enforce RELISTOR intellectual property rights.

In accordance with the Hatch-Waxman Act, Progenics and Valeant have 45 days after effective notice of the Paragraph IV certification to file suit...